✦ LIBER ✦

Origin and prognostic value of circulating KRAS mutations in lung cancer patients

✍ Scribed by O. Gautschi; B. Huegli; A. Ziegler; M. Gugger; J. Heighway; D. Ratschiller; P.C. Mack; P.H. Gumerlock; H.J. Kung; R.A. Stahel; D.R. Gandara; D.C. Betticher

Book ID: 116334433
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 491 KB
Volume: 254
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2007.03.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic value of loss of heterozygosi

Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma

✍ Laura De Gregorio; Giacomo Manenti; Matteo Incarbone; Silvana Pilotti; Ugo Pasto 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 89 KB

The prognostic values of loss of heterozygosity (LOH) at loci frequently involved in non-small cell lung cancer and of KRAS2 gene mutations were studied in lung adenocarcinoma patients. LOHs were relatively common, ranging from 24% at chromosome 10p to 55% at chromosome 17p13. KRAS2 mutations at cod

Prognostic value of circulating extracel

Prognostic value of circulating extracellular DNA in bladder cancer patients

✍ A. Font; M. Taron; J.L. Ramirez; M. Margeli; J. Areal; A. Barnadas; C. Balaña; J 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Detection of EGFR and KRAS mutations in

Detection of EGFR and KRAS mutations in circulating free DNA in patients with operable non small cell lung cancer (NSCLC)

✍ Board, R.; Shah, R.; Priest, L.; Bishop, P.; Ranson, M.; Hughes, A.N.; Dive, C.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

EGFR, ERBB2, and KRAS mutations in Korea

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients

✍ Nack Cheon Bae; Myung Hwa Chae; Myung Hoon Lee; Kyung Mee Kim; Eung Bae Lee; Cha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 515 KB

Predictive and prognostic value of KRAS

Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies

✍ Li-Xin Qiu; Chen Mao; Jian Zhang; Xiao-Dong Zhu; Ru-Yan Liao; Kai Xue; Jin Li; Q 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Circulating free DNA, p53 antibody and m

Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer

✍ Bozena Dobrzycka; Slawomir J. Terlikowski; Andrzej Mazurek; Oksana Kowalczuk; Wi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 616 KB

## Abstract This study was conducted to evaluate the significance of circulating free DNA (CFDNA), p53 antibody (p53‐Ab) and mutations of __KRAS__ gene in the development of endometrial cancer (EC). A total of 109 patients with EC (87 patients with Type I and 22 patients with Type II) took part in